Mivelsiran (ALN-APP) Investigational amyloid precursor protein-silencing RNAi therapy in Phase 2 development for cerebral amyloid angiopathy and Down syndrome-associated Alzheimer’s disease.
Visit productCosigns Received
Be the first Cosign
Put your name behind Mivelsiran (ALN-APP).
Add it to your Products I use list and share why you use it.